Cargando…
Current Approaches for Combination Therapy of Cancer: The Role of Immunogenic Cell Death
Cell death resistance is a key feature of tumor cells. One of the main anticancer therapies is increasing the susceptibility of cells to death. Cancer cells have developed a capability of tumor immune escape. Hence, restoring the immunogenicity of cancer cells can be suggested as an effective approa...
Autores principales: | Asadzadeh, Zahra, Safarzadeh, Elham, Safaei, Sahar, Baradaran, Ali, Mohammadi, Ali, Hajiasgharzadeh, Khalil, Derakhshani, Afshin, Argentiero, Antonella, Silvestris, Nicola, Baradaran, Behzad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226590/ https://www.ncbi.nlm.nih.gov/pubmed/32340275 http://dx.doi.org/10.3390/cancers12041047 |
Ejemplares similares
-
Varied functions of immune checkpoints during cancer metastasis
por: Safarzadeh, Ali, et al.
Publicado: (2020) -
MicroRNAs and lncRNAs—A New Layer of Myeloid-Derived Suppressor Cells Regulation
por: Safarzadeh, Elham, et al.
Publicado: (2020) -
From Melanoma Development to RNA-Modified Dendritic Cell Vaccines: Highlighting the Lessons From the Past
por: Shadbad, Mahdi Abdoli, et al.
Publicado: (2021) -
A Systematic Review on the Therapeutic Potentiality of PD-L1-Inhibiting MicroRNAs for Triple-Negative Breast Cancer: Toward Single-Cell Sequencing-Guided Biomimetic Delivery
por: Shadbad, Mahdi Abdoli, et al.
Publicado: (2021) -
Combination of Ipilimumab and Nivolumab in Cancers: From Clinical Practice to Ongoing Clinical Trials
por: Kooshkaki, Omid, et al.
Publicado: (2020)